Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Direct Acting Antiviral Agents”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03820102
What this trial is testing

Impact of Metabolic Changes and Vitamin D Status on Virological Response in Patients With HCV Infection Treated by DAAs

Who this might be right for
HCV
Assiut University 100
Testing effectiveness (Phase 2)Study completedNCT02583685
What this trial is testing

Switching Regimen in Treating Cirrhotic HCV GT1b Subjects

Who this might be right for
Chronic Hepatitis C Infection
Humanity and Health Research Centre 138
Testing effectiveness (Phase 2)Study completedNCT02118012
What this trial is testing

Evaluation of Safety, Tolerability, and Antiviral Activity of Chlorcyclizine HCl in Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 24
Large-scale testing (Phase 3)Study completedNCT02707601
What this trial is testing

Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV Treatment

Who this might be right for
HIV-1 InfectionHCV Infection
Gilead Sciences 150
Early research (Phase 1)Study completedNCT02824315
What this trial is testing

Study to Investigate the Pharmacokinetic Interaction Between 2 Direct Acting Antiviral Agents Odalasvir and AL-335 and Between 3 Direct Acting Antiviral Agents Simeprevir, Odalasvir and AL-335 at Steady State in Healthy Japanese Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 22
Not applicableStudy completedNCT04094272
What this trial is testing

Pulmonary Arterial Hypertension in Patients With Direct-Acting Antiviral Medications for Hepatitis C Virus Infection

Who this might be right for
Pulmonary Artery HypertensionChronic Hepatitis c
Kantonsspital Olten 49
Post-approval studies (Phase 4)WithdrawnNCT03623568
What this trial is testing

Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Kidney Transplant

Who this might be right for
Kidney FailureKidney DiseasesHepatitis C
Raymond T. Chung, MD
Post-approval studies (Phase 4)Ended earlyNCT03208244
What this trial is testing

DAA Treatment in Donor HCV-positive to Recipient HCV-negative Heart Transplant

Who this might be right for
End Stage Heart DiseaseHepatitis C
Massachusetts General Hospital 40
Not applicableStudy completedNCT03566966
What this trial is testing

Autoantibodies and Direct-acting Antivirals

Who this might be right for
Viral Hepatitis CTherapy Adverse Effect
University of Bari 191
Not applicableLooking for participantsNCT06928259
What this trial is testing

Drug-Drug Intercations and Direct Acting Antiviral Agents Against HCV

Who this might be right for
HCV Infection
University of Seville 728
Not applicableStudy completedNCT02969668
What this trial is testing

Interferon-free Antiviral Treatment of Chronic Hepatitis C Virus Infection Among Opioid-substituted Patients

Who this might be right for
Hepatitis C, ChronicOpioid-Related Disorders
Universitätsklinikum Hamburg-Eppendorf 326
Large-scale testing (Phase 3)UnknownNCT03163849
What this trial is testing

Assessment Effects After Direct Acting Antiviral in Chronic Hepatitis c Virus Patients

Who this might be right for
Chronic Hepatitis c
Assiut University 50
Not applicableStudy completedNCT03149289
What this trial is testing

Hepatitis C Virus Infection in Patients With Hemoglobinopathies

Who this might be right for
Hepatitis C, ChronicHemoglobinopathies
Società Italiana Talassemie ed Emoglobinopatie 168
Not applicableStudy completedNCT03902366
What this trial is testing

HCV and Co-morbid Alcohol Use Disorders: A Translational Investigation of Antiviral Therapy Outcomes on CNS Function

Who this might be right for
Hepatitis CAlcohol Use Disorder
VA Office of Research and Development 63
Large-scale testing (Phase 3)Study completedNCT02441283
What this trial is testing

Assess Resistance and Durability of Response to ABT-493 and/or ABT-530

Who this might be right for
Hepatitis C
AbbVie 384
Testing effectiveness (Phase 2)Study completedNCT01984294
What this trial is testing

Ledipasvir/Sofosbuvir Fixed-Dose Combination With Ribavirin or GS-9669 in Subjects With Chronic Genotype 1 HCV Infection

Who this might be right for
Chronic HCV Infection
Gilead Sciences 101
Not applicableUnknownNCT03481036
What this trial is testing

DAA Therapy in Pediatric Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis c
Post Graduate Institute of Medical Education and Research, Chandigarh 100
Not applicableUnknownNCT03268317
What this trial is testing

Neuropsychiatric Adverse Effects in Patients With Chronic Hepatitis C Treated by Direct Acting Antiviral Drugs

Who this might be right for
Hepatitis C
Assiut University 100
Testing effectiveness (Phase 2)Study completedNCT01435226
What this trial is testing

GS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 170
Not applicableUnknownNCT04242433
What this trial is testing

HCV RAS Testing in Public Health Programs

Who this might be right for
Hepatitis CPublic HealthDirect Acting Antiviral Agents+1 more
Post Graduate Institute of Medical Education and Research, Chandigarh 200
Next Page